Año: 2018
Journal Impact Factor (JIF): 11.8140
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
CLINICAL NEUROLOGY | SCIE | 6/199 | Q1 | T1 | D1 |
NEUROSCIENCES | SCIE | 11/267 | Q1 | T1 | D1 |
Año: 2018
Journal Citation Indicator (JCI): 3,240
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
CLINICAL NEUROLOGY | 6/251 | Q1 | T1 | D1 | 97,81 |
NEUROSCIENCES | 9/289 | Q1 | T1 | D1 | 97,06 |
Año:
2018
CiteScore:
17,600
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Neurology (clinical) | 6/341 | Q1 | T1 | D1 |
SJR año:
2018
Factor de Impacto:
5,978
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Medicine (miscellaneous) | 34/2805 | Q1 | T1 | D1 |
Neurology (clinical) | 4/391 | Q1 | T1 | D1 |
Agencia | Código de Proyecto |
---|---|
Abbvie | - |
Alzheimer Forschung Initiative e.V. PPMI | - |
Avid | - |
Biogen | - |
Bristol-Myers Squibb | - |
Covance | - |
GE Healthcare | - |
Genentech | - |
GlaxoSmithKline | - |
Golub Capital | - |
Lilly | - |
Lundbeek | - |
Merck | - |
Meso Scale Discovery | - |
Michael J. Fox Foundation for Parkinsons Research | - |
Pfizer | - |
Piramal | - |
Roche | - |
Servier | - |
Teva | - |
UCB | - |
# | Autor | Afiliación |
---|---|---|
1 | Ray, Nicola J. | Manchester Metropolitan University (United Kingdom) |
2 | Bradburn, Steven | Manchester Metropolitan University (United Kingdom) |
3 | Murgatroyd, Christopher | Manchester Metropolitan University (United Kingdom) |
4 | Toseeb, Umar | University of York (United Kingdom) |
5 | Mir, Pablo | Hospital Universitario Virgen del Rocío; CIBER Enfermedades Neurodegenerativas (Spain) |
6 | Kountouriotis, George K. | Manchester Metropolitan University (United Kingdom) |
7 | Teipel, Stefan J. | Universität Rostock; Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (Germany) |
8 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (Germany) |